Abstract
Aims/hypothesis: We aimed to characterise the development of autoregulation of glucose transport in vascular endothelial cells and its relationship to 12-lipoxygenase (12-LO) expression. Methods: Bovine aortic endothelial cells were exposed to 5.5 and 23.0 mmol/l glucose for up to 48 h. The rates of glucose transport, GLUT-1 and 12-LO expression and of 12-hydroxyeicosatetraenoic acid (12-HETE) production were determined. Results: We showed high glucose-dependent downregulation of glucose transport and transporter in vascular endothelial cells within 36-48 h. A similar time-dependent increase in the expression of 12-LO and the generation of its product 12-HETE was also observed. This downregulatory process was prevented when lipoxygenase activity was inhibited. Conclusions/interpretation: Vascular endothelial cells, which were previously thought to be "glucose-blind", do in fact downregulate GLUT-1 expression and the rate of glucose transport in response to extended exposure to high glucose concentrations. This slow development of glucose-induced downregulation in vascular endothelial cells is related to the slower basal rate of glucose transport in these cells and the slow induction of 12-LO. These data are interesting in view of current hypotheses that attribute vascular endothelial cell dysfunction in diabetes to the lack of a glucose-induced autoregulatory response.
Original language | English |
---|---|
Pages (from-to) | 752-755 |
Number of pages | 4 |
Journal | Diabetologia |
Volume | 48 |
Issue number | 4 |
DOIs | |
State | Published - Apr 2005 |
Externally published | Yes |
Bibliographical note
Funding Information:Acknowledgements S. Sasson is a member of The David R. Bloom Center for Pharmacy at the Hebrew University. E. Alpert and A. Gruzman received fellowships from The Hebrew University Center for Diabetes Research. This work was supported by grants from The Yedidut Foundation Mexico, The German–Israel Foundation for Scientific Research & Development (I-750-165.2/2002), and the Israel Ministry of Health.
Funding
Acknowledgements S. Sasson is a member of The David R. Bloom Center for Pharmacy at the Hebrew University. E. Alpert and A. Gruzman received fellowships from The Hebrew University Center for Diabetes Research. This work was supported by grants from The Yedidut Foundation Mexico, The German–Israel Foundation for Scientific Research & Development (I-750-165.2/2002), and the Israel Ministry of Health.
Funders | Funder number |
---|---|
Yedidut Foundation | |
German-Israeli Foundation for Scientific Research and Development | I-750-165.2/2002 |
Ministry of Health, State of Israel |
Keywords
- Endothelial cells
- Glucose transport
- Glucose transporter
- Hydroxyeicosatetraenoic acids
- Lipoxygenase
- Lipoxygenase inhibitors
- Vascular smooth muscle